Invasive Pneumococcal Disease in Infants Aged 0-60 Days in the United States in the 13-Valent Pneumococcal Conjugate Vaccine Era.

Liset Olarte,John S Bradley,Jill A Hoffman,Philana Ling Lin,Sheldon L Kaplan,William J Barson,Tina Q Tan,José R Romero,Kristina G Hultén,Laurence B Givner,Edward O Mason

doi:10.1093/jpids/pix034

Invasive Pneumococcal Disease in Infants Aged 0-60 Days in the United States in the 13-Valent Pneumococcal Conjugate Vaccine Era.

Liset Olarte, John S Bradley + Show 9 more

Open Access

https://doi.org/10.1093/jpids/pix034

Copy DOI

Journal: Journal of the Pediatric Infectious Diseases Society	Publication Date: May 16, 2017
Citations: 7

Affiliation: Baylor College of Medicine, Rady Children's Hospital-San Diego, University of Southern California, University of Pittsburgh, The Ohio State University, Northwestern University, University of Arkansas for Medical Sciences, Wake Forest University

#Invasive Pneumococcal Disease In Infants #Pneumococcal Disease In Infants + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

We identified 53 infants aged 0-60 days with invasive pneumococcal disease (IPD) at 8 children's hospitals in the United States (2005-2015). After the introduction of 13-valent pneumococcal conjugate vaccine (PCV13), IPD caused by PCV13 serotypes decreased ~30% providing some evidence of indirect protection. However, approximately 60% of IPD was still caused by PCV13 serotypes.

Full Text